Medicalgorithmics SA stock news
Medicalgorithmics SA has published its financial results for the first quarter of 2026, reporting a 51% year--over--year increase in consolidated revenue to PLN 10.2 million. The company achieved a positive EBITDA of PLN 1.1 million and operating cash flow of PLN 1.2 million, marking its second consecutive quarter above the operational cash break--even point. Performance was significantly bolstered by the U.S. market, which contributed PLN 4.7 million in revenue, a 105% increase compared to the same period last year. CEO Dr. Kris Siemionow noted that the results demonstrate the company's resilience despite external headwinds, such as severe weather in the United States and geopolitical instability in the Middle East.